Cite
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma
MLA
Munck af Rosenschöld, Magnus, et al. “Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-Difluorophenyl)(2-Fluoro-2-Methylpropyl)Amino]-3-Methoxypyrazin-2-Yl}carbonyl)Cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.” Journal of Medicinal Chemistry, no. Preprints, Jan. 2024. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.9b00555.
APA
Munck af Rosenschöld, M., Johannesson, P., Nikitidis, A., Tyrchan, C., Chang, H.-F., Rönn, R., Chapman, D., Ullah, V., Nikitidis, G., Glader, P., Käck, H., Bonn, B., Wågberg, F., Björkstrand, E., Andersson, U., Swedin, L., Rohman, M., Andreasson, T., Bergström, E. L., … Davis, A. M. (2024). Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. Journal of Medicinal Chemistry, Preprints. https://doi.org/10.1021/acs.jmedchem.9b00555
Chicago
Munck af Rosenschöld, Magnus, Petra Johannesson, Antonios Nikitidis, Christian Tyrchan, Hui-Fang Chang, Robert Rönn, Dave Chapman, et al. 2024. “Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-Difluorophenyl)(2-Fluoro-2-Methylpropyl)Amino]-3-Methoxypyrazin-2-Yl}carbonyl)Cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma.” Journal of Medicinal Chemistry, no. Preprints (January). doi:10.1021/acs.jmedchem.9b00555.